DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis

Review of 4 studies (n=1,933) found the use of DPP-4 inhibitors was associated with lower mortality vs no treatment OR 0.58, 95%CI 0.34-0.99). Authors highlight, as few relevant studies are available, more large-scale studies need to be performed.

Source:

PLOS ONE